Jubilant Life Sciences – Q4, FY20 results EBITDA was at Rs 1,555 Crore, up 13 per cent YoY with margin at 27.2 per cent, as compared with 25.7 per cent in FY19
Jubilant Bhartia Group contributes Rs 10 crore to PM Cares fund to combat COVID-19 Jubilant Foodworks, Jubilant Life Sciences contributed Rs 5 crore each to the fund
Jubilant Life Sciences develops formulation for hand sanitiser Jubilant Life Sciences has started supplying, free of cost hand sanitisers to Governments both at national, state level
